Catalys Pacific, LLC — 13F Holdings & Portfolio
CIK 2011385 · latest 13F-HR filed 2026-05-14
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$230.7M
Long-equity book
2
Distinct positions
2026-03-31
Filed 2026-05-14
+0 / −0 / ↑0 / ↓2
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- Mineralys Therapeutics, Inc.-$72.7M -25.4%
- Phathom Pharmaceuticals, Inc.-$7.1M -30.0%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | $230.7M | 2 | 0001104659-26-060911 |
| 2025-12-31 | 2026-02-10 | $310.5M | 2 | 0001104659-26-012485 |
| 2025-09-30 | 2025-11-14 | $351.4M | 2 | 0001104659-25-112029 |